In the News

Spironolactone is not associated with increased risk of female breast cancer recurrence, according to a study published in the Journal of the American Academy of Dermatology. “Spironolactone is used for androgenic alopecia because of its ability to halt the progression of hair loss and its long-...
Among premenopausal women with breast cancer, those who were previously treated with radiation for a primary childhood, adolescent, or young adult cancer have worse breast cancer-specific survival, according to a study published in Cancer Epidemiology, Biomarkers...
At-home genetic-testing kits for breast and ovarian cancer risk are just as effective, and in some cases even more so, than the typical protocol for genetic testing, which requires repeated office visits and counselling, according to a study published by the American Society of Clinical Oncology (...
An analysis of more than half a million women in Sweden revealed that mammography screening reduces the rates of advanced and fatal breast cancers. For the analysis, published in the journal Cancer, László Tabár, MD, Falun Central Hospital, Falun, Sweden, and colleagues examined data on nearly one...
Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at 6 months due to the small but not insignificant risk that the lesions are malignant, according to a study published in the journal Radiology. Breast Imaging and Reporting...

Conference Reports

By Jenny Powers

LUGANO, Switzerland -- September 23, 2020 -- The addition of atezolizumab to neoadjuvant nab-paclitaxel plus doxorubicin and cyclophosphamide significantly improved pathologic complete responses (pCR) compared with chemotherapy alone in patients with early triple-negative...

By Jenny Powers

LUGANO, Switzerland -- September 22, 2020 -- The addition of abemaciclib to endocrine therapy reduced the risk of breast cancer recurrence by 25.3% compared with endocrine therapy alone in patients with high-risk hormone receptor (HR)-positive, human epidermal growth...

By Nancy Melville

YORK, Me -- August 18, 2020 -- Neoadjuvant chemotherapy can enable patients with unfavourable tumour-to-breast ratios and large tumour size to convert from being ineligible to eligible for breast-conserving surgery with commonly successful outcomes, according to a study...

By Nancy Melville

YORK, Me -- August 18, 2020 -- Patients with breast cancer who receive surgery more than 4 weeks following neoadjuvant chemotherapy show higher rates of residual cancer burden and worse outcomes, according to a study presented at the 2020 Virtual Meeting of the Society...

By Ed Susman

NEW YORK -- June 3, 2020 -- In adults with tropomyosin receptor kinase (TRK) fusion cancers, larotrectinib demonstrated robust and durable tumour-agnostic efficacy and a favourable safety profile, according to a study presented at the American Society of Clinical Oncology (...

Recently Published

American Surgeon
Jessica Pastoriza, John McNelis, Afshin Parsikia, Erin Lewis, Marie Ward, Corrado P Marini, Maria T Castaldi
European Radiology
Fusun Taskin, Cem Burak Kalayci, Nermin Tuncbilek, Efe Soydemir, Nazmi Kurt, Handan Kaya, Erkin Aribal
JAMA Surgery
Shoshana M Rosenberg, Laura S Dominici, Shari Gelber, Philip D Poorvu, Kathryn J Ruddy, Julia S Wong, Rulla M Tamimi, Lidia Schapira, Steven Come, Jeffrey M Peppercorn, Virginia F Borges, Ann H Partridge
Australian and New Zealand Journal of Surgery (ANZ Journal of Surgery)
Alton Hong, Jonathan Chua, Michael Cheng, Michael Law
Expert Review of Anticancer Therapy
Romualdo Barroso-Sousa, Sara M Tolaney

Full-Text Articles

Scientific Reports
Niloufar Saharkhiz, Richard Ha, Bret Taback, Xiaoyue Judy Li, Rachel Weber, Alireza Nabavizadeh, Stephen A Lee, Hanina Hibshoosh, Vittorio Gatti, Hermes A S Kamimura, Elisa E Konofagou
Breast Cancer Research
Erica J Lee Argov, Teofilia Acheampong, Mary Beth Terry, Carmen B Rodriguez, Mariangela Agovino, Ying Wei, Shweta Athilat, Parisa Tehranifar
BMC Cancer
Blanca Murillo-Ortiz, Abraham Hernández-Ramírez, Talia Rivera-Villanueva, David Suárez-García, Mario Murguía-Pérez, Sandra Martínez-Garza, Allyson Rodríguez-Penin, Rosario Romero-Coripuna, Xiomara Midory López-Partida
Lancet Oncology
Nicholas C Turner, Belinda Kingston, Lucy S Kilburn, Sarah Kernaghan, Andrew M Wardley, Iain R Macpherson, Richard D Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C Winter, Hannah Bye, Michael Hubank, Heidrun Gevensleben, Ros Cutts, Claire Snowdon, Daniel Rea, David Cameron, Abeer Shaaban, Katrina Randle, Sue Martin, Katie Wilkinson, Laura Moretti, Judith M Bliss, Alistair Ring